Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer

Completed · Phase 2

Conditions studied: Breast Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Randomized phase II trial to compare the effectiveness of ISIS 5132 with ISIS 3521 in treating women who have metastatic breast cancer that has not responded to previous therapy.

Key facts

Study ID

NCT00003236

Run by

Eastern Cooperative Oncology Group

Starts

1998-07-13

Last updated by the study team

2023-06-18

Who can join

Age: 18 and older, up to 120. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Robert H. Lurie Comprehensive Cancer Center, Northwestern University — Chicago, Illinois, United States
• Veterans Affairs Medical Center - Chicago (Lakeside) — Chicago, Illinois, United States
• Indiana University Cancer Center — Indianapolis, Indiana, United States
• Johns Hopkins Oncology Center — Baltimore, Maryland, United States
• Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States
• University of Wisconsin Comprehensive Cancer Center — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.